Skip to main content
Premium Trial:

Request an Annual Quote

Foundation Medicine, MSKCC Partner on Companion Dx for Hematologic Cancer Treatments

NEW YORK (GenomeWeb News) – Foundation Medicine and Memorial Sloan-Kettering Cancer Center today said they are partnering to co-develop a molecular diagnostic tool to match patients who have hematologic cancers with the most appropriate targeted therapies or clinical trials.

The product will be based on Foundation Medicine's technology, methods, and computational algorithms, and will be developed using RNA and DNA sequencing, "to better enable identification of the unique genes and classes of genomic alterations that are characteristic of hematologic malignancies," Foundation Medicine and MSKCC said in a statement.

MSKCC will provide its clinical and genomic expertise to the effort.

The new test will be complementary to FoundationOne, Foundation Medicine's product launched last year for the genomic profiling of solid tumors, the Cambridge, Mass.-based company said. FoundationOne also provides reports to help physicians match patients with targeted therapies or clinical trials that are most appropriate for them.

The new test, anticipated to be launched by the end of the year, similarly will allow physicians to match genomic alterations with the most suitable targeted treatments for their patients.

Foundation Medicine plans to commercialize the test in the US and internationally.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.